In summary, our work represents the first study demonstrating a preferential expansion of activated CD4+ CD25+ FoxP3+ thymus‐derived Tregs exhibiting a Th2 phenotype in a mouse model of AD. This evidence concerns the gene CD4 and Alzheimer disease.